Your browser doesn't support javascript.
loading
Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom.
Chakraborty, Soumen; Uprety, Rajendra; Daibani, Amal E; Rouzic, Valerie L; Hunkele, Amanda; Appourchaux, Kevin; Eans, Shainnel O; Nuthikattu, Nitin; Jilakara, Rahul; Thammavong, Lisa; Pasternak, Gavril W; Pan, Ying-Xian; McLaughlin, Jay P; Che, Tao; Majumdar, Susruta.
Affiliation
  • Chakraborty S; Center for Clinical Pharmacology, University of Health Sciences & Pharmacy at St. Louis and Washington University School of Medicine, St. Louis, Missouri 63110, United States.
  • Uprety R; Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
  • Daibani AE; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
  • Rouzic VL; Center for Clinical Pharmacology, University of Health Sciences & Pharmacy at St. Louis and Washington University School of Medicine, St. Louis, Missouri 63110, United States.
  • Hunkele A; Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
  • Appourchaux K; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
  • Eans SO; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
  • Nuthikattu N; Center for Clinical Pharmacology, University of Health Sciences & Pharmacy at St. Louis and Washington University School of Medicine, St. Louis, Missouri 63110, United States.
  • Jilakara R; Department of Pharmacodynamics, University of Florida, Gainesville, Florida 032610, United States.
  • Thammavong L; Center for Clinical Pharmacology, University of Health Sciences & Pharmacy at St. Louis and Washington University School of Medicine, St. Louis, Missouri 63110, United States.
  • Pasternak GW; Center for Clinical Pharmacology, University of Health Sciences & Pharmacy at St. Louis and Washington University School of Medicine, St. Louis, Missouri 63110, United States.
  • Pan YX; Center for Clinical Pharmacology, University of Health Sciences & Pharmacy at St. Louis and Washington University School of Medicine, St. Louis, Missouri 63110, United States.
  • McLaughlin JP; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
  • Che T; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
  • Majumdar S; Department of Anesthesiology, Rutgers New Jersey Medical School, Newark, New Jersey 07103, United States.
ACS Chem Neurosci ; 12(14): 2661-2678, 2021 07 21.
Article in En | MEDLINE | ID: mdl-34213886
ABSTRACT
Dry leaves of kratom (mitragyna speciosa) are anecdotally consumed as pain relievers and antidotes against opioid withdrawal and alcohol use disorders. There are at least 54 alkaloids in kratom; however, investigations to date have focused around mitragynine, 7-hydroxy mitragynine (7OH), and mitragynine pseudoindoxyl (MP). Herein, we probe a few minor indole and oxindole based alkaloids, reporting the receptor affinity, G-protein activity, and ßarrestin-2 signaling of corynantheidine, corynoxine, corynoxine B, mitraciliatine, and isopaynantheine at mouse and human opioid receptors. We identify corynantheidine as a mu opioid receptor (MOR) partial agonist, whereas its oxindole derivative corynoxine was an MOR full agonist. Similarly, another alkaloid mitraciliatine was found to be an MOR partial agonist, while isopaynantheine was a KOR agonist which showed reduced ßarrestin-2 recruitment. Corynantheidine, corynoxine, and mitraciliatine showed MOR dependent antinociception in mice, but mitraciliatine and corynoxine displayed attenuated respiratory depression and hyperlocomotion compared to the prototypic MOR agonist morphine in vivo when administered supraspinally. Isopaynantheine on the other hand was identified as the first kratom derived KOR agonist in vivo. While these minor alkaloids are unlikely to play the majority role in the biological actions of kratom, they represent excellent starting points for further diversification as well as distinct efficacy and signaling profiles with which to probe opioid actions in vivo.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mitragyna / Alcoholism Limits: Animals Language: En Journal: ACS Chem Neurosci Year: 2021 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mitragyna / Alcoholism Limits: Animals Language: En Journal: ACS Chem Neurosci Year: 2021 Document type: Article Affiliation country: United States